DIRS.INFO The most relevant business & tech news

44 health care workers saw multiple cases of preteen children who had been shot in the head or chest in Gaza. 2 did not Merril Tydings Flight, emergency and critical care nurse, 44 years old, Santa Fe, N.M. “ These people were starving. ” Abeerah Muhammad Emergency and critical care nurse, 33 years old, Dallas, Texas “ Everyone we met showed us pictures of themselves before October. ” Merril Tydings Flight, emergency and critical care nurse, 44 years old, Santa Fe, N.M. “ It is very simple. ” 53 health care workers saw many children suffering from easily preventable infections, some of whom died from them.

Persons: Gaza Daniel Benneworth, Gray, I’ve, ”, Mimi Syed, Khan Younis, “, ” Dr, Mohamad Rassoul Abu, bariatric, Nina Ng, Dr, Mark Perlmutter, Mount, Irfan Galaria, Khawaja Ikram, Israel, Ahlia Kattan, Ndal Farah Anesthesiologist, ” Asma Taha, Nahreen Ahmed, Aman Odeh, Mike Mallah, Deborah Weidner, Tanya Haj, Hassan, ’, Laura Swoboda, Feroze, couldn’t, Mohammed Al, Adam Hamawy, Talal Ali Khan Nephrologist, Arham Ali, Loma, Newborn, ” Monica Johnston Burn, ” Brenda Maldonado, Ayman Abdul, Ghani, Ammar Ghanem, Mohamad Abdelfattah, ventilators, ” Laura Swoboda, Benjamin Netanyahu, Israel’s, Harris, ProPublica, Peter Beinart, Kamala Harris, Ms, it’s Organizations: Nurses, Gaza’s Ministry of Health, West Bank, Mark Perlmutter Orthopedic, “, United, Rights, Oxfam, United States, Israeli Defense Ministry, Committee, UNICEF, Gaza, Hamas, Biden, U.S Locations: Gaza, Ukraine, Haiti, Flint, Mich, Israel, Pittsburgh, Pa, New York City, N.Y, N.C, Chantilly, Va, “, Savannah, Ga, Dallas , Texas, Costa Mesa, Calif, Toledo , Ohio, Santa Fe, Portland, Philadelphia, Austin , Texas, Charleston, S.C, Hartford, Conn, Olympia, Wash, Mequon, Wis, Lathrop, Ohio, South Brunswick, N.J, Oklahoma City, Okla, Loma Linda, Vancouver, Honolulu, Hawaii, Detroit, Tustin, United States, U.S, Al, Lebanese

The findings bring the phenomenon — and the controversy — of the latest new and powerful weight loss drugs to the youngest age group yet. The new trial looked at liraglutide, the active ingredient used in two of Novo Nordisk’s older GLP-1 drugs: Saxenda, a weight loss drug, and Victoza, a diabetes drug. So instead of looking at overall weight loss like in adult studies, they decided to focus more on BMI, which takes into account both weight and height. A spokesperson for Novo Nordisk said that it has submitted an application to the Food and Drug Administration to expand the approval of liraglutide for weight loss in children ages 6 to 11. Is 6 too young for a weight loss drug?

Persons: Roy Kim, “, ” Kim, Claudia Fox, Fox, Eli Lilly, ”, liraglutide, ” Fox, Sarah Armstrong, ” Armstrong, comorbidities, it’s, ” Wegovy, Zepbound, Shauna Levy, ” Levy Organizations: New England, of Medicine, Novo Nordisk, Cleveland Clinic, Centers for Disease Control, University of Minnesota, BMI, Food and Drug Administration, American Academy of Pediatrics, Duke University, Tulane Bariatric Center Locations: liraglutide, Ozempic, Ohio, U.S, New Orleans

☆ Behind McKenzie Long’s Olympic debut, a mother’s love and a profound grief
▼ + stars: | 2024-08-03 | by ( Marcus Thompson Ii | ) www.nytimes.com time to read: +14 min

Then she was one of the darlings of the Olympic trials. It pushes me through.”Gabby Thomas and McKenzie Long embrace after the 200-meter at U.S. Olympic trials. Running for Ole Miss, McKenzie Long was 2024 NCAA outdoor champion in the 100- and 200-meter. I got us.”An open book like her mother, she’s talked of her bouts with anxiety, and how overwhelming the transition to professional has been. GO DEEPER Gabby Thomas, Olympic 200-meter favorite, is firmly in the spotlight — and ready for it(Top photo of McKenzie Long during U.S. Olympic trials: Charlie Neibergall / AP)

Persons: ” McKenzie Long, Long, Tara Elizabeth Jones, neé Murphy, Jones, “, ” Long, mascara, pouncing, it’s, she’d, Dang, Patrick Smith, could’ve, Sha’Carri Richardson, what’s, ”, Mom, “ You’re McKenzie Long, She’s, she’s, that’s, ” Gabby Thomas, McKenzie Long, Jake, Isaiah, McKenzie, Karmen — Jones, “ Tara, Lizzo, Jake Long, Kenzie, It’s, Ole, Morgan Engel, —, Bowerman, Michael, would’ve, Gabby Thomas, Jamaica’s Shericka Jackson, Saint Lucia’s Julien Alfred, Great, of Long, Charlie Neibergall Organizations: Adidas, U.S, Hayward, University of Oregon, Olympic, USA, Ole Miss, NCAA, Paris, Jones, West, North Carolina State’s, Carolina State’s, State, WSAZ News Locations: Hawaii, Eugene ,, Paris, Ironton , Ohio, West Virginia, Ironton, Columbus, North Carolina, N.C, State, N.C . State, America, Instagram

☆ Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
▼ + stars: | 2024-07-05 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +3 min

CNN —GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests. About 40% of new cancer diagnoses are associated with excess weight, according to the US Centers for Disease Control and Prevention. The risk was cut by more than half for gallbladder cancer, meningioma, pancreatic cancer and hepatocellular carcinoma, a kind of liver cancer. It was also significantly reduced for ovarian cancer, colorectal cancer, multiple myeloma, esophageal cancer, endometrial cancer and kidney cancer. And GLP-1 medications interact with systems related to insulin production.

Persons: CNN —, Dr, Sanjay Gupta Organizations: CNN, US Centers for Disease Control, JAMA, CNN Health, Case Western Reserve University School of Medicine

☆ ‘Sugary food is a drug for me’: A growing number of children are addicted to ultraprocessed foods
▼ + stars: | 2024-06-27 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +16 min

“I really gravitated towards the sugary ultraprocessed foods — it was like a physical drive, I had to have it,” he said. While many people addicted to food will say that their symptoms began to worsen significantly in adolescence, some recall a childhood focused on ultraprocessed food. The Institute of Food Technologists, an association of food professionals and technologists, does not agree with the research on ultraprocessed food addiction. “Children who eat a lot of ultraprocessed foods could well be malnourished.”According to the International Food and Beverage Alliance, however, there is no clear, objective, reliable or scientifically validated definition for “ultraprocessed” food. “Each time I would pray, ‘Please be it, please make this the answer.’ But I would ultimately start binging on ultraprocessed foods,” Odwazny said.

Persons: Jeffrey Odwazny, “, ”, Ashley Gearhardt, Ann Arbor, Gearhardt, ” Gearhardt, David Wiss, Bryan Hitchcock, Rocco Renaldi, Odwazny, ” Odwazny, ‘, ’ ”, Jeffrey Odwazny “, “ I’ve, ” Wiss, Sugar, Alexandra DiFeliceantonio, DiFeliceantonio, salivates, Laura Oliverio, —, Kimberly Dennis, Dennis, ‘ That’s, Kimmy Organizations: CNN, Chicago, Yale, University of Michigan, National Survey, Los, The, Food Technologists, World Health, International Food and Beverage Alliance, Food and Agriculture Organization, United Nations, Virginia Tech, Center, Health, Nutrition, University of Illinois Chicago College of Medicine, “ Locations: United States, Ann, Los Angeles, Blacksburg, Chicago, ’

☆ To help children with high BMI, expert panel recommends 26 hours of behavior coaching — but not weight-loss drugs
▼ + stars: | 2024-06-18 | by ( Jen Christensen | ) edition.cnn.com time to read: +9 min

The task force suggested that extensive and intensive behavioral interventions are the best way to help a child get to a healthy weight. A high BMI for a child is defined a little differently than it is for adults, although both use height and weight to estimate mass. Nearly 20% of children in the US have what’s considered a high BMI. The task force gives its guidelines letter grades based on the most up-to-date science. Under the Affordable Care Act, private insurers must cover preventive services that get a grade of A or B; the new child obesity recommendations got a B grade.

Persons: Susma Vaidya, ”, “, Dr, Mona Sharifi, ” Sharifi, Thomas Robinson, Sarah Armstrong, haven’t, Sharifi, Justin Ryder, Stanley Manne, Robert H, Lurie, “ I’ve, ” Ryder, Wegovy, Alli, Lomaira, John Ruiz, Sanjay Gupta, “ There’s, ” Vaidya, Vaidya, pharmacotherapy Organizations: CNN, US Preventive Services, Force, American Academy of Pediatrics, BMI, US Centers for Disease Control, Affordable, National Hospital, Yale School of Medicine, Stanford Solutions Science Lab, Department of Pediatrics, Pediatrics, Adolescent Health, Duke University Medical School, Stanley Manne Children’s, Ann, Lurie Children’s Hospital of Chicago, University of Arizona, CNN Health, FDA Locations: Washington

☆ Moms say their weight-loss drugs had a trickle-down effect — making their entire families healthier
▼ + stars: | 2024-05-30 | by ( Emily Farache | ) www.businessinsider.com time to read: +8 min

Read previewA vacation to Myrtle Beach last spring turned into a wake-up call for Jamie Bernardi and her family. Jamie BernardiThis is what researchers variously call the "trickle-down effect," "the ripple effect," or "the halo effect": when a person's lifestyle changes benefit their family members and close contacts who aren't under medical care. Doctors and researchers hope the trickle-down effect will help curb new cases of obesity. Taking controlThe trickle-down effect isn't just an added bonus. Just three weeks after she first jabbed her belly with Mounjaro, Bernardi bought everyone in her family generic watches to count their steps.

Persons: —, Jamie Bernardi, Bernardi, Keeley J, Pratt, Lisa Green, Green, Mounjaro, Lisa Green Lisa, it's, she'll, " Bernardi, Sandy Huffaker Organizations: Service, Business, CDC, Human, Science, The Ohio State University, Lisa Green Lisa Green People, The Washington, Getty Images Locations: Myrtle Beach, Weirton, West Virginia

☆ Ozempic doesn't make everyone thin. That opens up an opportunity for some stocks
▼ + stars: | 2024-05-27 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +7 min

Or, in other cases, it can open the door to new options for the treatment of obstructive sleep apnea. Treating obesity and addressing sleep apnea Sleep apnea is a serious sleep disorder that results in interrupted breathing, preventing patients — and even their sleeping partners — from getting restful and restorative sleep. Obstructive sleep apnea, the most common form, occurs when muscles in the throat relax and collapse preventing air flow. Before qualifying for the device, patients usually need to have tried treatment with a CPAP machine and an oral device and been unsuccessful. He downgraded Inspire shares to hold at the beginning of the year due to this uncertainty he was anticipating.

Persons: Eli Lilly's Zepbound, Anthony Petrone, Medical's, Eli Lilly, Tim Herbert, Zepbound, Herbert, FactSet, Petrone, UnitedHealth, Jonathan Block Organizations: Novo Nordisk's, Mizuho Securities, CNBC, Systems, Inspire, American Diabetes Association, Drug Administration, National Institutes of Health, BMI Locations: U.S

In addition to Wegovy and Ozempic, the GLP-1 class includes Eli Lilly's highly popular weight loss drug Zepbound and diabetes treatment Mounjaro. VanGilder signed up nearly four years ago and started taking the weekly diabetes injection Ozempic specifically for weight loss. The big difference between Calibrate and prior weight loss efforts, VanGilder said, is that she doesn't feel like she's dieting. Calibrate is one of the only companies to regularly release reports detailing the results of its weight loss program. The federal Medicare program by law can't cover weight loss drugs unless the prescription is for another approved health benefit, such as diabetes or cardiovascular health.

Persons: Michael Siluk, Gray Beard, She'd, that's, Beard, wouldn't, She's, Ro, Goldman Sachs, Eli Lilly's, it's, Andrew Dudum, There's, Zachariah Reitano, Reitano, Wegovy, WeightWatchers, Gary Foster, Foster, Oprah Winfrey's, Kim Gradwell, Lee Smith, Jennifer VanGilder, she'd, Jenny Craig, VanGilder, I've, Kristin Baier, Rob MacNaughton, Ro's Reitano, we'd, Eli Lilly, Craig Primack, Primack, Hims, Dudum, We're Organizations: — Novo, UCG, Novo Nordisk, CNBC, Teladoc Health, World Health Organization, Food, WeightWatchers Clinic, Ursinus College, Asset Management Locations: Charlotte , North Carolina, U.S, Dudley , North Tyneside, Britain, Collegeville , Pennsylvania, Hims

☆ I had bariatric surgery and lost 120 pounds. It allowed me to run my first half-marathon at age 45.
▼ + stars: | 2024-05-21 | by ( Jane Ridley | ) www.businessinsider.com time to read: +7 min

Before I lost 120 pounds, I could barely run a mile, let alone the length of a proper race. I'd always been heavy-set, but by the time I reached my early 30s in 2010, my weight was a big issue. My heaviest weight was 350 poundsHe told me that he'd had gastric sleeve surgery and never looked back. AdvertisementQuintano had gastric sleeve surgery in April 2023 Courtesy of Anthony QuintanoMeanwhile, I'd developed a blood clot in my leg. I started walking laps around my hospital room.

Persons: —, Anthony Quintano, I'd, munch, Quintano, he'd, Anthony, you've, I've Organizations: Service, Business, KFC, Brooklyn, New York City Marathon Locations: Brooklyn, Maine, New Jersey, Central, New York

☆ Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all
▼ + stars: | 2024-05-21 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +8 min

Professional organizations have set this as a guideline for when to reassess whether a treatment is providing clinically meaningful weight loss. People who met with their providers less frequently – and those living in underserved regions with broader health inequities – were more likely to discontinue GLP-1 treatment sooner. But using GLP-1 treatments are still an investment in many ways. These injected medications, called GLP-1 agonists, are in high demand because they have proved to be so effective for weight loss. And experts warn that the GLP-1 treatment process can be different for everyone.

Persons: ”, Disha, Wegovy, Jody Dushay, Beth, There’s, Razia Hashmi, ” Hashmi, it’s, “, Dr, Sanjay Gupta, ” Narang, ” Dushay Organizations: CNN, Endeavor Health, Beth Israel Deaconess Medical Center, Harvard Medical School, Shield, Dandelion Health, CNN Health, “ Locations: Chicago, –, GLP

☆ I tried making the viral Caesar chicken-crust pizza, and I get why the easy high-protein dish is so popular on TikTok
▼ + stars: | 2024-05-08 | by ( Terri Peters | ) www.businessinsider.com time to read: +1 min

I tried the high-protein, low-carb Caesar-salad chicken-crust pizza I keep seeing on TikTok. The dish uses canned chicken to make a low-carb, high-protein pizza crust and is easy to make. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . Millions of TikTok users have viewed Caesar-salad chicken-crust pizza videos in which creators share recipes and promise the viral dish tastes fresh and flavorful. So, I made the viral Caesar-salad chicken-crust pizza in my own kitchen — and my family and I were pleasantly surprised.

Persons: — Organizations: Service

☆ Medicare can now cover certain weight loss drugs in a big step for patients
▼ + stars: | 2024-03-21 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Medicare can start covering certain weight loss drugs for the first time — as long as they are approved for an added health benefit, the Centers for Medicare and Medicaid Services said Thursday. Medicare prescription drug plans administered by private insurers, known as Part D, currently cannot cover those drugs for weight loss alone. A provision of a 2003 law established that Medicare Part D plans can't cover drugs used for weight loss, but the program does cover obesity screening, behavioral counseling and bariatric surgery. A CMS spokesperson told CNBC last week that Medicaid programs would be required to cover Wegovy specifically for its new cardiovascular use. Around 1 in 5 state Medicaid programs currently cover GLP-1 drugs for weight loss.

Persons: Ozempic, Eli Lilly Organizations: Novo Nordisk, Medicare, Centers, Services, Drug, Food and Drug Administration, CVS, Aetna, International Foundation of Employee, CNBC, FDA Locations: London, Britain, U.S

☆ Oprah Winfrey tears up recounting her weight loss journey in primetime special
▼ + stars: | 2024-03-18 | by ( Megan Thomas | ) edition.cnn.com time to read: +3 min

CNN —It’s been nearly 13 years since “The Oprah Winfrey Show” came to an end, but for viewers of her weight loss special on Monday night, it likely felt like Winfrey’s talk show was back. “An Oprah Special: Shame, Blame and the Weight Loss Revolution” featured Winfrey doing what she proved for 25 seasons on “The Oprah Winfrey Show” she can do better than just about anyone else: bring people together and get them talking – and listening – to each other. Winfrey, too, shared the pain she has felt at times in her weight journey. “It’s not a matter of willpower.”The medical experts addressed potential side effects of weight loss medications and factors and risks that should be considered before taking it as part of a multiifaceted care plan. Winfrey spoke about her use of weight loss medication as one “tool” to manage her weight, combined with hiking, running, weight resistance training and eating a healthy diet.

Persons: CNN — It’s, Oprah Winfrey, ”, “, Winfrey, ” Winfrey, Scott Butsch, Amanda Velazquez, It’s, ” Butsch, “ It’s, Let’s Organizations: CNN, Obesity, Metabolic, Cleveland Clinic Locations: United States, Sinai, Los Angeles

☆ Thinking about taking new weight loss drugs? These are the big health risk decisions that will follow
▼ + stars: | 2024-02-28 | by ( Eric Rosenbaum | ) www.cnbc.com time to read: +6 min

In this article NOVO.B-DKLLYWWGWW Follow your favorite stocks CREATE FREE ACCOUNTAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. But will Americans trust the most iconic brand in the legacy weight-loss business to guide them into its future? "Big pharma was coming for weight loss, and if they didn't have a clinical angle, they would have run the risk of becoming an irrelevant company." "This is a new, incredibly powerful and effective class of pharmaceuticals that a lot of people will find help improve their health." watch nowRisks of overreliance on obesity drugs The risk is real that providers may use the medications and "forget about lifestyle," said John Batsis, an associate professor and nutrition expert at the University of North Carolina Chapel Hill's school of public health.

Persons: Eli Lilly’s, Brendan Mcdermid, Eli Lilly, —, Sima Sistani —, Sistani, Alex Fuhrman, Hallum, Fuhrman, Davidson, Linda Bolton Weiser, I've, Geoff Cook, Cook, John Batsis, Batsis Organizations: Reuters, Novo Nordisk, CNBC, Craig, pharma, University of North, University of North Carolina Chapel Locations: New York City, U.S, Herbalife, University of North Carolina

☆ Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
▼ + stars: | 2024-02-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +8 min

Victoria Klesty | ReutersThe insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments. The dominant weight loss drugmakers, Novo Nordisk and Eli Lilly , have said supply woes likely won't go away anytime soon, as the popularity of those medicines continues to soar. Some Wall Street analysts project that the weight loss drug market could be worth $100 billion by the end of the decade. But both Novo Nordisk and Eli Lilly gave updates on positive supply developments to investors over the last week. Other forms of weight loss drugs could helpAlternative forms of weight loss drugs could also help alleviate supply constraints in the future.

Persons: Victoria Klesty, Eli Lilly, Cantor Fitzgerald, Louise Chen, Nordisk's Wegovy, Eli Lilly's Zepbound, Goldman Sachs, Jeff Friedman, Novo, Mike Segar, Eli, Catalent, Yves Herman Yves Herman, TD Cowen, Michael Nedelcovych, Anat Ashkenazi, Cantor Fitzgerald's Chen, Morgan Stanley, Eli Lilly's, George Frey Organizations: Novo Nordisk, CNBC, Nordisk's, University of Florida, Pfizer, AstraZeneca, Roche, Food, Nordisk, Company, FDA, Novo Holdings, Wegovy, REUTERS, Reuters, U.S Locations: Oslo, Norway, Novo, U.S, Branchburg , New Jersey, Brussels, Belgium, Catalent, Concord , North Carolina, North, Germany, Indiana, Denmark, France

☆ What to know about medications like Ozempic, Wegovy, Mounjaro and Zepbound for weight loss
▼ + stars: | 2024-02-03 | by ( Andrea Kane | ) edition.cnn.com time to read: +8 min

Editor’s note: Season 9 of the podcast Chasing Life With Dr. Sanjay Gupta explores the intersection between body weight and health. But anyone who has ever dieted can tell you that losing weight is hard and that long-term weight loss requires sustained effort, which can sometimes feel Herculean, even impossible. If you are considering starting one of these medications, Moreno recommends keeping these five facts in mind. “On average, with semaglutide, the weight loss average can be close to 15%. This is the time to start changing some eating patterns that will be beneficial for weight loss.

Persons: Sanjay Gupta, Ozempic, It’s, Jorge Moreno, Moreno, ‘ You’ve, ”, ” Moreno, “, Tirzepatide, Food and Drug Administration — “, They’re, ” They’re, —, “ It’s, GERD, ” It’s, ’ ” Moreno Organizations: CNN, Yale School of Medicine, LinkedIn, Food and Drug Administration

☆ 4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry
▼ + stars: | 2024-01-15 | by ( Jim Cramer | ) www.cnbc.com time to read: +12 min

We will go over them – but first, let me talk about what I learned at last week's JPMorgan Health Care Conference that I attended in San Francisco, and what it means to your portfolio. We know health care has a lot of angles too it. The previous CEO Roz Brewer was from Starbucks and struggled with the role that Walgreens plays in health care. You have to be following the transformation of Bristol-Myers, which is opening its wallet to buy a host of drug companies, including anti-psychotic firm Karuna. Health care is the way to go.

Persons: Regeneron, Pfizer, Eli Lilly, Dave Ricks, Lilly, donanemab, Lilly's, Zepbound, it's, Abbott, It's, Roche, Merck, Myers, ABT, Robert Ford, Tim Wentworth, He's, Roz Brewer, Wentworth, he'll, Brewer wasn't, Bob Bradway, Amgen, Vas Narasimhan, Sandoz, Karuna, Medtronic, Hugo, Morgan Stanley, Wells, Covid, Cramer's, Jim Cramer, Jim, Las Vegas Brendan Smialowski Organizations: Abbott Labs, Covid, Novartis, Amgen, Walgreens Boots Alliance, JPMorgan Health Care Conference, Humana, Drug Administration, Novo Nordisk, Dickinson Co, Bristol, Myers Squibb, Pfizer, Department, WBA, Walgreens, Starbucks, -, pharma, Merck, Keytruda, Horizon Therapeutics, Federal Trade Commission, Myers, BD, CVS Health, JPMorgan, Cramer's Charitable, CNBC, Consumer, AFP, Getty Locations: San Francisco, GLP, North Carolina, Europe, Cencora, Amgen, West, Bristol, Target, Las Vegas

☆ Oprah's flip on weight loss drugs is a sign of what's to come for the 'Ozempic trade' in 2024
▼ + stars: | 2023-12-25 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +10 min

Lilly's Zepbound recently entered the weight loss market, and is off to a strong start. But what's ahead for the weight loss trade in 2024? Beyond weight loss One of 2023's most pivotal events in the space was Novo Nordisk's release of top line results from its Select trial in August . In 2023, the exuberance around weight loss drugs roiled markets in many unexpected ways. The affected companies have also been very vocal in addressing how they plan to coexist with these weight loss products.

Persons: Oprah Winfrey, Eli Lilly, they've, Lilly's, Lilly's Zepbound, Andy Acker, Janus Henderson's, Lilly, Novo, FactSet, Acker, Janus, Buzz, Gregory Renza, Renza, Goldman Sachs, Chris Shibutani, Mike Kratky, Kratky, Dexcom, Leerink, Winfrey, I've, Winfrey's, Michael Bloom Organizations: Novo Nordisk, Wall Street, Wall, RBC Capital, Pfizer, Structure Therapeutics, AstraZeneca, Leerink, Nestle, Oprah Daily, Winfrey, International Locations: Friday's, Eccogene, MedTech, 3Q23

☆ Bariatric Surgery at 16
▼ + stars: | 2023-10-31 | by ( Helen Ouyang | ) www.nytimes.com time to read: +4 min

It’s the exact opposite.” The number of teenagers who underwent bariatric surgery more than doubled nationwide between 2010 and 2017 and continues to rise. Seeley emphasizes that weight loss doesn’t simply result from a newly tiny stomach that limits how much people can eat. The crucial roles instead seem to be played by bile acids and antimicrobial peptides in the gut, each of which increase markedly after surgery; Seeley is still sorting out the exact mechanisms of their influence. “Why bariatric surgery works so well is because you’re changing lots of things at the same time,” Seeley says. Most important, bariatric surgery seems to reset, to a lower bound, the body weight that the brain tries to maintain.

Persons: Rodriguez, “, ”, Alexandra, ” Gabriela, ” Rodriguez, Thomas Inge, Randy Seeley, Seeley, ” Seeley, “ I’m, ” Inge, I’d, “ We’ve Organizations: Teen, National Institutes of Health, Lurie Children’s Hospital, University of Michigan Locations: United States, Chicago

Such forecasts have prompted a sell-off in a wide range of companies from makers of bariatric surgery devices to companies whose products address the health issues created by excess weight, from diabetes to sleep apnea. "The market is in a shoot-first, ask-questions-later mood when it comes to weight-loss drugs," said Nicholas Anderson, manager of the Thornburg International Growth Fund, which holds shares of Novo Nordisk. By contrast, the iShares U.S. Medical Devices exchange-traded fund has lost more than 22% in the last three months. Injectable weight-loss drugs, known as GLP-1 receptor agonists, are considered highly effective but are also expensive, costing more than $1,300 per month. "Overall, we'll see an increased interest in bariatric surgery, but that will get delayed in the short term."

Persons: Doctor Thomas Horbach, Wegovy, Nicholas Anderson, Eli Lilly, Kenneth Stein, Margaret Kaczor Andrew, William Blair, Michael Farrell, Jeff Jonas, Johnson, Myriam Curet, Ann Hynes, Hynes, David Gaffen, Manas, Michael Erman, Caroline Humer, Sonali Paul Organizations: Novo Nordisk, Healthcare, Growth Fund, Medical Devices, Boston, Gabelli Funds, Johnson, Reuters, Mizuho Securities, Manas Mishra, Thomson Locations: Germany, Munich, Danish, U.S, Boston, GLP, New York, Bengaluru

☆ AI, weight loss drugs and more: Portfolio manager names stocks to play 'new secular growth themes'
▼ + stars: | 2023-10-24 | by ( Amala Balakrishner | ) www.cnbc.com time to read: +4 min

And then you overlay on top of that the emergence of two or three brand new secular growth themes," he said. CNBC Pro takes a look at the stocks he likes in three "brand new" areas of growth: obesity drugs, reshoring and artificial intelligence. Reshoring infrastructure Ayer sees bright spots in the reshoring theme too. The portfolio manager named tech giant Amazon as a good play of the AI wave. The way Ayer sees it, more companies in the U.S. are foraying into AI right now, compared to those in other parts of the world.

Persons: Sanjay Ayer, Ayer, He's bullish, —, Christina Cheddar Berk, Carmen Reinicke, Julie Coleman Organizations: CNBC Pro, WCM Investment Management, Equity Fund, Nordisk, Novo Nordisk, U.S . Food, Drug Administration, Tetra Tech, Canadian, Canadian Pacific, U.S Locations: U.S, China, Japan, India

☆ Robot maker Intuitive's sales miss as weight-loss drugs cut into bariatric surgery demand
▼ + stars: | 2023-10-19 | by ( Khushi Mandowara | ) www.reuters.com time to read: +2 min

Oct 19 (Reuters) - Intuitive Surgical (ISRG.O) missed analysts' estimates for quarterly sales on Thursday and flagged sagging demand for its robots used in bariatric surgeries amid the growing popularity of weight-loss drugs. Shares of the da Vinci surgical robots maker tumbled nearly 7.8% to $252 in trading after the bell. On Tuesday, Johnson & Johnson (JNJ.N) signaled a hit to sale of devices used to perform abdomen surgeries such as bariatric. Such patients will eventually become increasingly interested in bariatric surgery but this will get delayed in the short term, Curet said. Bariatric surgeries grew at modestly lower rate in third quarter compared to the previous quarter, financial head Jamie Samath said, adding the company was gaining market share in the surgical segment.

Persons: Johnson, Myriam Curet, Curet, Jamie Samath, Khushi, Sriraj Organizations: Thomson Locations: U.S, Bengaluru

☆ Corporate America weighs risks of the Ozempic effect
▼ + stars: | 2023-10-19 | by ( ) www.reuters.com time to read: +3 min

Walmart (WMT.N) expects revenues from its health and wellness products to increase in the second half of the year, mainly due to the popularity of weight-loss drugs. PepsiCo (PEP.O) Chief Financial Officer Hugh Johnston has said the company is "not seeing any impact" yet from the popularity of weight-loss drugs. Abbott Laboratories (ABT.N), which makes glucose monitoring products, has said that the market was overestimating the impact to its sales from growing popularity of the drugs. Abbott CEO Robert Ford has said that diabetes patients could end up using glucose monitors with the weight-loss drugs in the long term. DRUG DISTRIBUTORSCencora (COR.N), formerly called AmerisourceBergen, Cardinal Health (CAH.N) and McKesson (MCK.N) have flagged potential boost to revenues this year owing to the growing demand for weight-loss drugs.

Persons: George Frey, Eli Lilly's, Hugh Johnston, Johnson, Joseph Wolk, Robert Ford, Bhanvi, Mrigank Organizations: Novo Nordisk, Pharmacy, REUTERS, Walmart, PepsiCo, Abbott Laboratories, Insulet Corp, Cardinal Health, Thomson Locations: Provo , Utah, U.S, Bengaluru

☆ GLP-1 weight loss drugs are creating opportunities for these 2 stocks, investment advisor says
▼ + stars: | 2023-10-18 | by ( Weizhen Tan | ) www.cnbc.com time to read: +3 min

Developments surrounding the drugs, also popularly used for weight loss, have been disrupting anything from owners of dialysis centers to bariatric surgery providers and the food industry. But one investment advisor, Brian Krawez, president of Scharf Investments, says there are opportunities. "Many investors are concerned about the impacts of the GLP-1 drugs on a host of companies ranging from restaurants to consumer staples. Those mechanisms are the ones that help patients taking the drugs to lose weight and regulate their diabetes. They got roughly 35% market share, but a lot of people don't know the company," he said, adding that specialty pharmaceuticals — including the GLP-1 drugs —account for roughly 35% of the company's earnings.

Persons: Brian Krawez, Scharf, Mounjaro, Krawez, CNBC's, McKesson, It's, —, Christina Cheddar Berk, Julie Coleman Organizations: Scharf Investments, CNBC, Novo Nordisk, Walmart, Unilever, Unilever isn't Locations: GLP, U.S

Search resuls for: "bariatric"

25 mentions found